Tissue Engineering and Regenerative Medicine

The field of regenerative medicine is comprised of an estimated 120 public and 600 private companies as well as a plethora of universities. This vital community of major research institutions and companies are succeeding in advancing both the basic science and its translation into clinical testing and commercial products. In a Blue Economy, the current unsustainable models of production and consumption will be outdated and eliminated. A vicious cycle of over-exploitation of labor and the Earth, with an ever-increasing burden of carbon emissions, will cease. It will become a virtuous cycle of using what is available, increasing social capital incrementally and bringing innovations to the marketplace that help meet the basic needs of all. The blue economy can enhance our lifestyles, benefit our planet and use and conserve materials and energy in remarkable ways.